You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD34 selection

Showing 1 - 25 of 9,197
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

Not yet recruiting
  • AML
  • +5 more
  • Infusion of CD34 selected hematopoietic stem cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 14, 2023

B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Cyclophosphamide injection
  • +2 more
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Jan 18, 2023

Apheresis of Patients With Immunodeficiency

Recruiting
  • LAD-1
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent Trial in Maywood (Fludarabine,

    Active, not recruiting
    • B-Cell Acute Lymphoblastic Leukemia, Adult
    • +2 more
    • Maywood, Illinois
      Loyola University
    Aug 11, 2022

    Malignant Non-Hodgkin Lymphomas Trial in Berne (CD34+ cell selection)

    Active, not recruiting
    • Malignant Non-Hodgkin Lymphomas
    • CD34+ cell selection
    • Berne, Switzerland
      Department for Medical Oncology; University Hospital/Inselspital
    Jul 29, 2021

    Hematologic Malignancies Trial in Chicago, New York (device, drug, radiation)

    Recruiting
    • Hematologic Malignancies
    • CliniMACS® CD34 Reagent System
    • +7 more
    • Chicago, Illinois
    • +1 more
    Sep 20, 2022

    Leukemia, Myelocytic, Acute Trial in United States (CD34+ selection with CliniMACS device)

    Completed
    Has Results
    • Leukemia, Myelocytic, Acute
    • CD34+ selection with CliniMACS device
    • Duarte, California
    • +7 more
    Oct 21, 2021

    Malignant Diseases (ie, Leukemia, MDS, Lymphoma), Non-malignant Diseases (ie, Bone Marrow Failure Syndromes) Trial in Milwaukee

    Completed
    • Malignant Diseases (ie, Leukemia, MDS, Lymphoma)
    • Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
    • CliniMACS (CD+3, CD+19 depletion)
    • +2 more
    • Milwaukee, Wisconsin
      Children's Hospital of Wisconsin
    Oct 21, 2021

    MDS (Myelodysplastic Syndrome), Myeloproliferative Disorder, Lymphoma, Non-Hodgkin Trial run by the NHLBI (Graft Manipulation

    Completed
    Has Results
    • MDS (Myelodysplastic Syndrome)
    • +4 more
    • Graft Manipulation (CD34+ Selection)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 20, 2020

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell

    No longer available
    • Acute Lymphoblastic Leukemia
    • +11 more
    • CD34+ enriched, T Cell Depleted donor stem cell product
    • San Francisco, California
      University of California, San Francisco
    May 25, 2021

    Hematologic Disorders Trial in Aurora (Miltenyi CliniMACS® CD34 Reagent System)

    Recruiting
    • Hematologic Disorders
    • Miltenyi CliniMACS® CD34 Reagent System
    • Aurora, Colorado
      University of Colorado
    Feb 22, 2022

    Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

    No longer available
    • Chronic Myeloid Leukemia
    • +2 more
    • G-CSF mobilized CD34+ selected cells for transplantation
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    Feb 28, 2022

    Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

    Withdrawn
    • Hematologic Diseases
    • +5 more
    • CliniMACS
    • +7 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Sep 26, 2022

    Sickle Cell Disease Trial in Paris (DREPAGLOBE drug product)

    Active, not recruiting
    • Sickle Cell Disease
    • DREPAGLOBE drug product
    • Paris, France
      Department of Biotherapy, Necker-Enfants Malades Hospital
    Sep 26, 2022

    Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS

    Recruiting
    • Chronic Myeloid Leukemia (CML)
    • +5 more
    • CliniMACS CD34+ Reagent System
    • +8 more
    • New York, New York
      Columbia University Medical Center
    Jun 17, 2020

    MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Miami, Florida
      Miami Cancer Institute
    Jan 10, 2023

    Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia Trial in New York (CD34 Stem Cell Selection

    Active, not recruiting
    • Bone Marrow Failure Syndrome
    • +15 more
    • CD34 Stem Cell Selection Therapy
    • New York, New York
      Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
    Jun 17, 2020

    Retinitis Pigmentosa Trial in Sacramento (Intravitreal autologous CD34+ cells)

    Recruiting
    • Retinitis Pigmentosa
    • Intravitreal autologous CD34+ cells
    • Sacramento, California
      University of California Davis
    Sep 1, 2022

    Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow

    Available
    • Benign Neoplasm
    • +3 more
    • Bone Marrow Transplantation
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Dec 9, 2021

    Mucopolysaccharidosis II Trial (Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII)

    Not yet recruiting
    • Mucopolysaccharidosis II
    • Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII
    • (no location specified)
    Dec 16, 2022

    Mitochondrial Diseases, Pearson Syndrome Trial in Ramat Gan (MNV-201)

    Recruiting
    • Mitochondrial Diseases
    • Pearson Syndrome
    • MNV-201
    • Ramat Gan, Israel
      Sheba Medical Center
    Aug 24, 2023

    Metastatic Non-Small Cell Lung Carcinoma Trial in Seoul (Pembrolizumab Injection)

    Recruiting
    • Metastatic Non-Small Cell Lung Carcinoma
    • Pembrolizumab Injection
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Nov 6, 2022

    Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Miami (Total Body Irradiation (TBI), Thiotepa, Cyclophosphamide)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • Leukemia, Lymphocytic, Acute
    • Total Body Irradiation (TBI)
    • +5 more
    • Miami, Florida
      Baptist Health South Florida/Miami Cancer Institute
    Nov 28, 2022

    CD34 + Stem Cells and Biological Markers of Angiogenesis in

    Recruiting
    • Vasculopathy
    • Heart Transplant Failure
    • coronary CT angiography
    • Ljubljana, Slovenia
      Advanced Heart Failure and Transplantation Center, University Me
    Aug 2, 2022

    Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Dresden, Heidelberg (Donor-derived CD34+ HSC with CRISPR/Cas9-mediated

    Not yet recruiting
    • Relapsed/Refractory Acute Myeloid Leukemia (AML)
    • Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion
    • Gemtuzumab Ozogamicin
    • Dresden, Germany
    • +1 more
    Dec 20, 2022